Cover Image
市場調查報告書

Adamed Sp. z o.o.:產品平台分析

Adamed Sp. z o.o. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256085
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
Adamed Sp. z o.o.:產品平台分析 Adamed Sp. z o.o. - Product Pipeline Review - 2015
出版日期: 2015年04月29日 內容資訊: 英文 28 Pages
簡介

Adamed Sp. z o.o.從事著處方藥、成藥及藥用化妝品的開發、製造及上市。該公司的處方藥適用於治療心臟、精神系統、神經系統、肺臟、過敏及婦科相關疾病等。

本報告提供Adamed Sp. z o.o.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Adamed Sp. z o.o.的基本資料

Adamed Sp. z o.o.概要

  • 主要資訊
  • 企業資料

Adamed Sp. z o.o.:R&D概要

  • 主要的治療範圍

Adamed Sp. z o.o.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Adamed Sp. z o.o.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Adamed Sp. z o.o.:藥物簡介

  • ADN-06
  • ADN-0965
  • ADN-1184
  • ADN-2013
  • ADN-3662
  • ADO-514
  • ADN-2157
  • ONCO-3CLA
  • Small Molecule for Schizophrenia
  • Small Molecule to Agonize mGluR2 for Anxiety Disorders
  • Small Molecule to Inhibits MDM2 and MDM4 for Cancer

Adamed Sp. z o.o.:開發平台分析

  • 標的別
  • 各分子類型
  • 各作用機制

Adamed Sp. z o.o.:暫停中的計劃

Adamed Sp. z o.o.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07025CDB

Summary

Global Markets Direct's, 'Adamed Sp. z o.o. - Product Pipeline Review - 2015', provides an overview of the Adamed Sp. z o.o.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Adamed Sp. z o.o.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Adamed Sp. z o.o. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Adamed Sp. z o.o.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Adamed Sp. z o.o.'s pipeline products

Reasons to buy

  • Evaluate Adamed Sp. z o.o.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Adamed Sp. z o.o. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Adamed Sp. z o.o.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Adamed Sp. z o.o. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Adamed Sp. z o.o.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Adamed Sp. z o.o. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Adamed Sp. z o.o. Snapshot
    • Adamed Sp. z o.o. Overview
    • Key Information
    • Key Facts
  • Adamed Sp. z o.o. - Research and Development Overview
    • Key Therapeutic Areas
  • Adamed Sp. z o.o. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Adamed Sp. z o.o. - Pipeline Products Glance
    • Adamed Sp. z o.o. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Adamed Sp. z o.o. - Drug Profiles
    • ADN-06
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADN-0965
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADN-1184
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADN-2013
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADN-3662
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADO-514
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADN-2157
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ONCO-3CLA
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Schizophrenia
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Agonize mGluR2 for Anxiety Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibits MDM2 and MDM4 for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Adamed Sp. z o.o. - Pipeline Analysis
  • Adamed Sp. z o.o. - Pipeline Products by Target
  • Adamed Sp. z o.o. - Pipeline Products by Molecule Type
  • Adamed Sp. z o.o. - Pipeline Products by Mechanism of Action
  • Adamed Sp. z o.o. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Adamed Sp. z o.o., Key Information
  • Adamed Sp. z o.o., Key Facts
  • Adamed Sp. z o.o. - Pipeline by Indication, 2015
  • Adamed Sp. z o.o. - Pipeline by Stage of Development, 2015
  • Adamed Sp. z o.o. - Monotherapy Products in Pipeline, 2015
  • Adamed Sp. z o.o. - Preclinical, 2015
  • Adamed Sp. z o.o. - Discovery, 2015
  • Adamed Sp. z o.o. - Pipeline by Target, 2015
  • Adamed Sp. z o.o. - Pipeline by Molecule Type, 2015
  • Adamed Sp. z o.o. - Pipeline Products by Mechanism of Action, 2015
  • Adamed Sp. z o.o., Subsidiaries

List of Figures

  • Adamed Sp. z o.o. - Pipeline by Top 10 Indication, 2015
  • Adamed Sp. z o.o. - Pipeline by Stage of Development, 2015
  • Adamed Sp. z o.o. - Monotherapy Products in Pipeline, 2015
  • Adamed Sp. z o.o. - Pipeline by Top 10 Target, 2015
  • Adamed Sp. z o.o. - Pipeline by Top 10 Molecule Type, 2015
  • Adamed Sp. z o.o. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top